Gladius Capital Management »

Corcept Therapeutics Incorporated shares owned by Gladius Capital Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Gladius Capital Management from 13F filings

Historical chart of Gladius Capital Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Gladius Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Gladius Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $36k 1.1k 32.48
2022-06-30 $31k 1.3k 24.07

More positions owned by Gladius Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Put Put Option
Apple Put Put Option
Microsoft Corp Put Put Option
Ishares Gold Tr Ishares New (IAU)
Apple Call Call Option
Advanced Micro Devices Put Put Option
Alphabet Put Put Option
Micron Technology Put Put Option
Nvidia Corporation Put Put Option
Microsoft Corp Call Call Option
Amazon Call Call Option
Amazon Put Put Option
Broadcom Put Put Option
Meta Platforms Put Put Option

View all positions for Gladius Capital Management

Top funds holding Corcept Therapeutics Incorporated

Vanguard Group
Ingalls & Snyder
Parallel Advisors
Dimensional Fund Advisors
Norden Group
Btim
Federated Investors
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Charles Schwab Investment Management
Man Group
Norges Bank Investment Management
Bank of New York Mellon
Millennium Management
Kynam Capital Management

View all funds holding Corcept Therapeutics Incorporated